These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7069325)

  • 1. Electrophysiologic effects of mexiletine on normal and ischemic ventricles.
    Yoon MS; Han J
    J Electrocardiol; 1982 Apr; 15(2):109-13. PubMed ID: 7069325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil on ventricular rhythm during acute coronary occlusion.
    Fondacaro JD; Han J; Yoon MS
    Am Heart J; 1978 Jul; 96(1):81-6. PubMed ID: 655114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of mexiletine on the excitability and vulnerability of the dog ventricle (author's transl)].
    Márquez Montes J; Vera Almazán A; Esteve Alderete JJ; Puente Rodero B; Montero C; Castillo-Olivares JL
    Arch Farmacol Toxicol; 1981 Dec; 7(3):307-18. PubMed ID: 7337470
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology and clinical use of mexiletine.
    Fenster PE; Comess KA
    Pharmacotherapy; 1986; 6(1):1-9. PubMed ID: 3513138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
    Duff HJ; Gault NJ
    J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmias following one-stage and two-stage coronary reperfusion: evidence for both reentry and enhanced automaticity.
    Kabell G; Scherlag BJ; Brachmann J; Harrison L; Lazzara R
    J Electrocardiol; 1985 Jan; 18(1):87-96. PubMed ID: 2579181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophysiologic actions of mexiletine (Kö-1173) in man].
    González Maqueda I; García Fernández F; Martín Jadraque L
    Med Clin (Barc); 1981 Mar; 76(5):223-5. PubMed ID: 7206892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mexiletine on monophasic action potentials recorded from the right ventricle in man.
    Harper RW; Olsson SB; Varnauskas E
    Cardiovasc Res; 1979 Jun; 13(6):303-10. PubMed ID: 476751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mexiletine on conduction of premature ventricular beats in man: a study using monophasic action potential recordings from the right ventricle.
    Harper RW; Olsson SB
    Cardiovasc Res; 1979 Jun; 13(6):311-9. PubMed ID: 476752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.
    Yamaguchi I; Singh BN; Mandel WJ
    Cardiovasc Res; 1979 May; 13(5):288-96. PubMed ID: 476749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of mexiletine in children.
    Shakibi JG; Moezzi B
    Jpn Heart J; 1982 Sep; 23(5):733-8. PubMed ID: 7176082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mexiletine on the electrophysical properties of the intact human heart.
    Harper RW; Olsson SB; Varnauskas E
    Scand J Clin Lab Invest; 1977 Oct; 37(6):503-7. PubMed ID: 616069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenic effects of mexiletine in infarcted Purkinje tissues.
    Han J; Derhsam GH; O'Connell DP
    J Electrocardiol; 1989 Jan; 22(1):81-7. PubMed ID: 2921581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine action on the specialized tissues of the human heart.
    Pozzoni L; Romano S; Beltrami A; Calosso E; Verzoni A; Longoni A; Croce L
    Int J Clin Pharmacol Res; 1985; 5(4):229-36. PubMed ID: 4055166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral mexiletine on left and right ventricular function.
    Stein J; Podrid P; Lown B
    Am J Cardiol; 1984 Sep; 54(6):575-8. PubMed ID: 6475776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological mechanisms for the antiarrhythmic action of mexiletine on digitalis-, reperfusion- and reoxygenation-induced arrhythmias.
    Amerini S; Carbonin P; Cerbai E; Giotti A; Mugelli A; Pahor M
    Br J Pharmacol; 1985 Dec; 86(4):805-15. PubMed ID: 4075017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.